Rna-Seq Cancer Cell Line, Hg19 Or Cancer Cell Line Genome?
Just curious,
I never worked with cancer data before and I was wondering if it's not recommended to use the generic H.sapiens reference genome builds such as hg19
Should I build the .ebwt files using the genome from the specific cancer cell line, which in fact has a validated translocation?
I'm leaning towards the cancer cell line, but my reads are around 35bp in length after QC. So I'm guessing that it wouldn't really matter because of this?
Thanks a lot!
• 2,895 views
•
link
updated
by
Biostar
•
written
by
QVINTVS_FABIVS_MAXIMVS
•
written
by
QVINTVS_FABIVS_MAXIMVS
1 answer
Does the translocation interrupt a transcription event? If not, the mapping will be approximately the same regardless.
• 155 views
•
link
written
by
Devon Ryan
Log in to answer this question.
More posts like this
-
How to Predict Drug Targets Using Single-Sample RNA-Seq Data?
written by Musab •
-
How to find the insertion site of GFP in viral genome using RNA-Seq?
written by Prisca :) •
-
How to find the insertion site of GFP in viral genome using RNA-Seq?
written by Prisca :) •
-
Should I keep or remove the alignment reads whose mate reads mapped to a different chr ?
written by dingailuma •
-
Confusion regarding generating phylogenetic tree from snp data
written by ehzed •
-
Assosiation of candidate genes after drug pertubations with specific cancer type and known drug int…
written by svlachavas
-
filtering pileup file with samtools for SomaticSniper
written by TriS
-
ChIP-seq in cancer cell lines
written by Ming Tommy Tang
-
Rna-Seq Paired End 76 Bp Read Data From Sra To Fastq To Bam
written by dfernan
-
How Many Differing Snv To Expect Between Two Cancer Samples With Identical Origin?
written by fubioinf •
